Header Logo

Connection

Kelly Standifer to Opioid Peptides

Back to Details
This is a "connection" page, showing publications Kelly Standifer has written about Opioid Peptides.
Kelly Standifer
Connection Strength
3.293
Opioid Peptides
  1. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ. Mol Pharmacol. 2013 May; 83(5):907-18.
    View in: PubMed
    Score: 0.415
  2. Increased nociceptive sensitivity and nociceptin/orphanin FQ levels in a rat model of PTSD. Mol Pain. 2012 Oct 20; 8:76.
    View in: PubMed
    Score: 0.406
  3. Sex differences in the Nociceptin/Orphanin FQ system in rat spinal cord following chronic morphine treatment. Neuropharmacology. 2012 Sep; 63(3):427-33.
    View in: PubMed
    Score: 0.393
  4. Orphanin FQ/nociceptin activates nuclear factor kappa B. J Neuroimmune Pharmacol. 2011 Dec; 6(4):617-25.
    View in: PubMed
    Score: 0.367
  5. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation. Mol Pharmacol. 2005 Aug; 68(2):447-56.
    View in: PubMed
    Score: 0.243
  6. Traumatic Brain Injury Induces Nociceptin/Orphanin FQ and Nociceptin Opioid Peptide Receptor Expression within 24 Hours. Int J Mol Sci. 2024 Jan 29; 25(3).
    View in: PubMed
    Score: 0.222
  7. Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation. Brain Res Mol Brain Res. 2002 Sep 30; 105(1-2):38-46.
    View in: PubMed
    Score: 0.202
  8. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk. J Pharmacol Exp Ther. 2002 Aug; 302(2):502-9.
    View in: PubMed
    Score: 0.200
  9. Therapeutic potential of nociceptin/orphanin FQ peptide (NOP) receptor modulators for treatment of traumatic brain injury, traumatic stress, and their co-morbidities. Pharmacol Ther. 2022 03; 231:107982.
    View in: PubMed
    Score: 0.188
  10. Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells. Neurosci Lett. 2001 Feb 23; 299(3):173-6.
    View in: PubMed
    Score: 0.181
  11. Exacerbated Headache-Related Pain in the Single Prolonged Stress Preclinical Model of Post-traumatic Stress Disorder. Cell Mol Neurobiol. 2021 Jul; 41(5):1009-1018.
    View in: PubMed
    Score: 0.176
  12. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Br J Pharmacol. 2015 Jan; 172(2):571-82.
    View in: PubMed
    Score: 0.114
  13. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity. J Pharmacol Exp Ther. 2003 Sep; 306(3):965-72.
    View in: PubMed
    Score: 0.053
  14. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure. Neuropharmacology. 2002 Nov; 43(6):979-90.
    View in: PubMed
    Score: 0.051
  15. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells. Eur J Pharmacol. 2000 Aug 18; 402(1-2):R1-37.
    View in: PubMed
    Score: 0.044
  16. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. J Pharmacol Exp Ther. 1994 Sep; 270(3):1246-55.
    View in: PubMed
    Score: 0.029
  17. Characterizing kappa3 opioid receptors with a selective monoclonal antibody. Synapse. 1996 Mar; 22(3):247-52.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.